HL036

HL036 · HanAll BioPharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HL036, covering 2016-12-09 to 2022-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes [Phase 3]